Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
about
Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burdenInterferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.Immune control and failure in HCV infection--tipping the balance.Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.IFN-λ4: the paradoxical new member of the interferon lambda family.Pharmacogenomics of antimicrobial agents.Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysisHepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study.Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.Interferon lambda 4 expression is suppressed by the host during viral infection.Innate and adaptive genetic pathways in HCV infection.Targeting IFN-λ: therapeutic implications.Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.Contribution of type III interferons to antiviral immunity: location, location, location.IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection.Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.Does the interferon-lambda rather than the interferon-alpha pathway determine the outcome of hepatitis C virus infection?IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.Immunopathogenesis of Hepatitis C Virus Infection.
P2860
Q28255239-0FFCED5A-3819-4FD6-BC7A-73B38BFDA4E4Q33600034-8698E444-275E-4DD5-A953-7A981182A72CQ33944295-7C72699F-14E5-49B5-BD96-BFAEEAA3CAE2Q34178628-AB3FC80A-D048-4EC9-861A-F35130D67115Q34433087-9CFBC94C-289E-4A92-A8A7-1ACB3E712A49Q34439917-4AA79728-6BE2-49EB-951B-DA46E45948BEQ34977413-C5C4DD2E-8783-474D-B532-CBFCBE104271Q35370579-3D7CA103-1FCA-4A15-B639-B33BD2877488Q35852736-33497597-2E49-440A-B475-136AAB037EB6Q36201137-79CE12B5-82F0-4A27-9A39-10486BE592ECQ36274463-5007C771-ACE7-436E-A3B3-BC203609698FQ36395264-7BA6F873-5748-448D-8E9F-A7CA69FF69DAQ36450748-9897D2B3-FD5A-43F2-876B-0D147719E170Q37252581-CA21AB67-2666-4C6B-8423-36C486AA9863Q37415224-A2407857-0A8A-4A60-B19E-EBE36C3BE598Q38364524-31C204FB-4749-44C1-AA03-5EE7215B65A2Q38816811-0D626A29-8367-499A-ADDF-988CE1F13843Q38859455-3A88BF6A-81AA-4480-B4F8-DF0F6C3D6CFFQ39176570-618C4C3D-24D5-42EA-8142-FDD7F6CE1020Q40113190-4B19AF59-5CFF-4262-A559-DBCD485738AEQ40390455-9AFDE959-A531-44AE-A6FF-3E6525354CE1Q40564211-1E919789-40C5-44FF-8EF0-257B64BAA48CQ41528209-E9066D9A-4348-48C3-8734-FBE598544FE8Q41711786-61A4B4C6-D209-4673-8B77-A427C5195E89Q42202740-AFF4D887-6DD9-4AAE-AFF0-2186ADD695CEQ47600393-B610C85A-29AA-497C-8F47-EBC64C3EDAA7Q50934385-95315845-FE1E-40AA-A675-33CD136A609C
P2860
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@ast
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@en
type
label
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@ast
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@en
prefLabel
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@ast
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@en
P2093
P2860
P1433
P1476
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
@en
P2093
Ahmad Amanzada
Giuliano Ramadori
Sabine Mihm
Ulrich Spengler
Waltraut Kopp
P2860
P304
P356
10.1371/JOURNAL.PONE.0084026
P407
P577
2013-12-20T00:00:00Z